Drug intelligence / Profile preview

Encover

Development stage
Unknown
Lead developer
JW Pharmaceutical
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral, Enteral
01

Overview

Encover is a liquid enteral nutrition product developed and marketed by JW Jungwoo Pharmaceutical (a subsidiary of JW Pharmaceutical). It is a specialized nutritional formula designed for patients who are unable to maintain adequate oral intake or who have impaired digestion or absorption. Encover provides a balanced profile of essential macronutrients, including proteins (typically casein and soy protein), carbohydrates (maltodextrin), and fats, along with a comprehensive range of vitamins and minerals. It is particularly indicated for the nutritional management of patients with inflammatory bowel diseases such as Crohn's disease, as well as for post-operative recovery and patients requiring tube feeding. In the South Korean market, it is often regulated as a prescription (ethical) drug due to its specific medical indications.

Brand names
Encover
Other names
Encover Liquid

Beyond the preview

Go deeper on Encover.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Encover.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call